Table 3

Diabetic pharmacotherapy use among those individuals holding at least one valid prescription for an antihyperglycemic agent at the time of initial ccCHiP clinic visit (n=229)

Antihyperglycemic agentn (%) holding a valid prescription
Metformin216 (94.3)
Gliclazide (or other sulfonylurea)44 (19.2)
DPP4 inhibitor26 (11.4)
GLP-1 receptor agonist1 (0.4)
SGLT2 inhibitor17 (7.4)
Insulin36 (15.7)
  • ccCHiP, Collaborative Centre for Cardiometabolic Health in Psychosis.